Efficacy of glucagon-like peptide-1 receptor agonists for prevention of stroke among patients with and without diabetes: A meta-analysis with the SELECT and FLOW trails
Treatment with GLP-1 receptor agonists has beneficial effects in reducing the risk of stroke, and nonfatal stroke in patients with and without diabetes. However, no such effect was observed for fatal stroke.
Authors
- Zarghoona Wajid (ORCID: https://orcid.org/0009-0003-3379-576X)
- Sidra Naz (ORCID: https://orcid.org/0000-0001-6390-9658)
- Asmita Gera (ORCID: https://orcid.org/0000-0002-0312-8208)
- Fakhar Latif
- Vivek Mittal (ORCID: https://orcid.org/0000-0002-4764-7413)
- Tanisha Prasad (ORCID: https://orcid.org/0000-0001-6037-2277)
- Jishanth Mattumpuram (ORCID: https://orcid.org/0000-0002-6359-3435)
- Novonil Deb (ORCID: https://orcid.org/0000-0002-9005-8358)
- Vikash Jaiswal (ORCID: https://orcid.org/0000-0002-2021-1660)
- Vamsikalyan Borra (ORCID: https://orcid.org/0000-0002-9595-5699)
- Fathima Shehnaz Ayoobkhan (ORCID: https://orcid.org/0000-0002-9642-4961)
- Tushar Kumar (ORCID: https://orcid.org/0000-0003-4078-4754)
Institutions
- Trinity Health (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Louisville (US)
- Royal College of Surgeons in Ireland (IE)
- University of Washington (US)
- The University of Texas Rio Grande Valley (US)
- Larkin Community Hospital (US)
- Dow University of Health Sciences (PK)
- North Bengal Medical College and Hospital (IN)
- Wuqing District People's Hospital (CN)
- Hennepin Healthcare Research Institute (US)
- Tianjin Medical University (CN)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2025-03-16
- DOI
- https://doi.org/10.1016/j.ijcha.2025.101638
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29